Shared Content Block

There's a hidden style tag here that puts more space between items in bulleted and numbered lists (so they don't all run together).

Emerging Assays


Additional Biomarker Research

Novel biomarkers for early detection of cancer

  1. miRNA as a biomarker in Early Detection of Lung Cancer: Here we are developing miRNA signatures for tumor versus normal tissue with a review of the literature.  We ultimately anticipate demonstrating miRNA signatures in plasma which may determine cancer in high-risk patients diagnosed with lung nodules by CT-Scan.  Here we also have acquired an HTG Edge system to improve miRNA recovery from plasma using a unique nuclease protection chemistry.
  2. Volatile Organic Compounds (VOCs) in Exhaled Breath: In collaboration with the laboratory of Dr. Hossam Haick at Technion University in Israel, unique VOC signatures are determined from breath samples employing a novel gold nanoparticle microarray detector and compared to data from GC/MS.

Novel biomarkers for determination of cancer cells

  1. Development of assays including IHC, mRNA ISH, SISH, CISH or PLA for new and emerging targets including Frizzled 1-2, and FGF ligands, among others.
  2. Working with major funding agencies to evaluate antibodies for important targets such as PD-L1 using Laboratory Derived Tests which are optimized on autostainer platforms such as the Dako Link48 or the Ventana Benchmark XT.